ESSA Pharma Inc.'s (NASDAQ:EPIX) hedge funds investors lost 12% last week but have benefitted from longer-term gains

Key Insights Given the large stake in the stock by institutions, ESSA Pharma's stock price might be vulnerable to their...

Related Keywords

,Pharma Inc ,Bellevue Asset Management ,Soleus Capital Management ,Essa Pharma ,Institutional Investors ,Ssa Pharma Inc ,Nsider Ownership ,Hedge Funds Investors ,Hedge Funds ,